deferoxamine has been researched along with exudates in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Aljunid, SM; Dahlui, M; Hishamshah, MI; Rahman, AJ | 1 |
Chai, PF; Lee, WS; Soo, TL; Toh, TH | 1 |
Kuppusamy, UR; Tan, JA | 1 |
Chhabra, IK; Ibrahim, HM; Mohammed, NS; Shafie, AA; Wong, JHY | 1 |
4 other study(ies) available for deferoxamine and exudates
Article | Year |
---|---|
Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment.
Topics: Adolescent; Adult; Blood Transfusion; Child; Cross-Sectional Studies; Deferoxamine; Female; Follow-Up Studies; Humans; Iron Overload; Malaysia; Male; Quality of Life; Siderophores; Surveys and Questionnaires; Thalassemia; Treatment Outcome | 2009 |
Self-reported level of and factors influencing the compliance to desferrioxamine therapy in multitransfused thalassaemias.
Topics: Adolescent; Adolescent Behavior; Blood Transfusion; Caregivers; Child; Child Behavior; Child, Preschool; Cross-Sectional Studies; Deferoxamine; Female; Ferritins; Health Knowledge, Attitudes, Practice; Humans; Interviews as Topic; Malaysia; Male; Medication Adherence; Multivariate Analysis; Siderophores; Thalassemia | 2011 |
Chelation therapy with desferrioxamine does not normalize ferritin level but attenuates oxidative damage and improves total antioxidant level in Malaysian Chinese beta-thalassaemia major patients.
Topics: Adolescent; Analysis of Variance; beta-Thalassemia; Case-Control Studies; Chelation Therapy; Child; China; Deferoxamine; Female; Ferritins; Glutathione Peroxidase; Humans; Lipid Peroxides; Malaysia; Male; Oxidative Stress; Siderophores; Xanthine Oxidase | 2011 |
Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective.
Topics: Benzoates; Blood Transfusion; Cost of Illness; Cross-Sectional Studies; Deferasirox; Deferoxamine; Humans; Malaysia; Quality of Life; Thalassemia; Triazoles | 2021 |